Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05564273
What this trial is testing

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

Who this might be right for
Metabolic Health
Viome 150
Not applicableLooking for participantsNCT01257269
What this trial is testing

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Who this might be right for
Thrombotic Thrombocytopenic PurpuraCongenital Thrombotic Thrombocytopenic PurpuraFamilial Thrombotic Thrombocytopenic Purpura+2 more
Insel Gruppe AG, University Hospital Bern 450
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Not applicableStudy completedNCT04473976
What this trial is testing

Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects

Who this might be right for
Migraine
IRCCS National Neurological Institute "C. Mondino" Foundation 55
Early research (Phase 1)Looking for participantsNCT07586618
What this trial is testing

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Who this might be right for
Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL
Allterum Therapeutics, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00006390
What this trial is testing

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00308620
What this trial is testing

Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine

Who this might be right for
HIV Infections
University of Minnesota 13
Not applicableNot Yet RecruitingNCT06698120
What this trial is testing

Awake Prone Positioning for Severe Acute Chest Syndrome

Who this might be right for
Acute Chest SyndromeSickle Cell Anemia
Assistance Publique - Hôpitaux de Paris 15
Testing effectiveness (Phase 2)Study completedNCT00745420
What this trial is testing

Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 30
Not applicableStudy completedNCT02698982
What this trial is testing

Optimized Anesthesia to Reduce Postoperative Cognitive Impairment in the Elderly

Who this might be right for
Elderly ; Moderate Risk Surgery
Erasme University Hospital 41
Not applicableStudy completedNCT04826523
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 150
Not applicableActive Not RecruitingNCT06405880
What this trial is testing

Pharmacist Case Finding and Intervention for Vascular Prevention Trial

Who this might be right for
Cardiovascular Risk FactorsBlood PressureCardiovascular Disease+2 more
University of Alberta 1,003
Testing effectiveness (Phase 2)WithdrawnNCT00148980
What this trial is testing

Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesMyelofibrosis
Hadassah Medical Organization 24
Large-scale testing (Phase 3)Study completedNCT01568580
What this trial is testing

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 71
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT03047746
What this trial is testing

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF

Who this might be right for
Acquired Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaInherited Bone Marrow Failure Syndromes
Children's Hospital of Philadelphia 50
Not applicableUnknownNCT01487746
What this trial is testing

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

Who this might be right for
Ischemic Stroke
Meir Medical Center 207
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Not applicableStudy completedNCT00691561
What this trial is testing

Culturally-Tailored HIV Risk Reduction for African-American MSM

Who this might be right for
HIV Infections
Medical College of Wisconsin 220
Next Page